204
Participants
Start Date
January 3, 2020
Primary Completion Date
April 8, 2022
Study Completion Date
June 23, 2022
NMRA-335140
Active Drug
Placebo
Placebo
Neumora Investigator Site, New York
Neumora Investigator Site, Staten Island
Neumora Investigator Site, Brooklyn
Neumora Investigator Site, Jamaica
Neumora Investigator Site, Rochester
Neumora Investigator Site, Decatur
Neumora Investigator Site, Atlanta
Neumora Investigator Site, Atlanta
Neumora Investigator Site, Atlanta
Neumora Investigator Site, Fernandina Beach
Neumora Investigator Site, Jacksonville
Neumora Investigator Site, Orlando
Neumora Investigator Site, Orlando
Neumora Investigator Site, Miami Lakes
Neumora Investigator Site, Lauderhill
Neumora Investigator Site, Sarasota
Neumora Investigator Site, Memphis
Neumora Investigator Site, Dayton
Neumora Investigator Site, Little Rock
Neumora Investigator Site, Bentonville
Neumora Investigator Site, Oklahoma City
Neumora Investigator Site, Wichita Falls
Neumora Investigator Site, Clinton
Neumora Investigator Site, Phoenix
Neumora Investigator Site, Las Vegas
Neumora Investigator Site, Culver City
Neumora Investigator Site, Torrance
Neumora Investigator Site, Bellflower
Neumora Investigator Site, Long Beach
Neumora Investigator Site, Glendale
Neumora Investigator Site, Sherman Oaks
Neumora Investigator Site, Upland
Neumora Investigator Site, Riverside
Neumora Investigator Site, Santa Ana
Neumora Investigator Site, Garden Grove
Neumora Investigator Site, Oakland
Neumora Investigator Site, San Jose
Neumora Investigator Site, Berlin
Lead Sponsor
Neumora Therapeutics, Inc.
INDUSTRY